Palatin Announces the Initiation of a Phase 2 Clinical Study of Bremelanotide Co-Administered With a Pde5I for the Treatment of Erectile Dysfunction (Ed)
Palatin宣佈啓動第2期臨床研究,研究Bremelanotide與Pde5I聯合治療勃起功能障礙(ED)
Palatin Announces the Initiation of a Phase 2 Clinical Study of Bremelanotide Co-Administered With a Pde5I for the Treatment of Erectile Dysfunction (Ed)
Palatin宣佈啓動第2期臨床研究,研究Bremelanotide與Pde5I聯合治療勃起功能障礙(ED)
譯文內容由第三人軟體翻譯。